Rosen Law Firm is informing investors about a class action filed on behalf of shareholders of Alto Neuroscience following its recent IPO. This alert is crucial for those affected as it outlines their rights and the potential implications of the ongoing litigation.
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto’s initial public offering conducted on or about February 2, 2024 (the “IPO”); and/or (ii) securities between February 2, 2024 and October 22, 2024. Alto describes itself as a “clinical-stage biopharmaceutical company in the U.S.” For more infor
Source: Original Press Release